Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Director/PDMR Shareholding

5 Mar 2013 14:35

Tate & Lyle PLC

Director/PDMR Shareholding

Tate & Lyle PLC (the “Company”) was informed yesterday that Matthew Wineinger, a Person Discharging Managerial Responsibility, disposed of 12,100 ordinary 25p shares in the Company (“Shares”) on 4 March 2013 on the NASDAQ at a price of 818.53 pence per Share (being the equivalent of US$12.35 per Share using an exchange rate of 1.5088) in order to meet a tax liability arising on the release of Shares under the Group’s executive share incentive plans in 2012.

This notification is made in accordance with DTR 3.1.4R(1)(a) of the FSA’s Disclosure and Transparency Rules.

Lucie Gilbert

Company Secretary

5 March 2013

Copyright Business Wire 2013

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.